Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1T84

Solution structure of the Wiskott-Aldrich Syndrome Protein (WASP) autoinhibited core domain complexed with (S)-wiskostatin, a small molecule inhibitor

Summary for 1T84
Entry DOI10.2210/pdb1t84/pdb
Related1CEE 1EJ5
DescriptorWiskott-Aldrich syndrome protein, (2S)-1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN-2-OL (2 entities in total)
Functional Keywordsalpha helix, beta-hairpin turn, signaling protein
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm, cytoskeleton: P42768
Total number of polymer chains1
Total formula weight12029.74
Authors
Peterson, J.R.,Bickford, L.C.,Morgan, D.,Kim, A.S.,Ouerfelli, O.,Kirschner, M.W.,Rosen, M.K. (deposition date: 2004-05-11, release date: 2004-07-13, Last modification date: 2024-05-22)
Primary citationPeterson, J.R.,Bickford, L.C.,Morgan, D.,Kim, A.S.,Ouerfelli, O.,Kirschner, M.W.,Rosen, M.K.
Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation.
Nat.Struct.Mol.Biol., 11:747-755, 2004
Cited by
PubMed Abstract: Current drug discovery efforts focus primarily on proteins with defined enzymatic or small molecule binding sites. Autoregulatory domains represent attractive alternative targets for small molecule inhibitors because they also occur in noncatalytic proteins and because allosteric inhibitors may avoid specificity problems inherent in active site-directed inhibitors. We report here the identification of wiskostatin, a chemical inhibitor of the neural Wiskott-Aldrich syndrome protein (N-WASP). Wiskostatin interacts with a cleft in the regulatory GTPase-binding domain (GBD) of WASP in the solution structure of the complex. Wiskostatin induces folding of the isolated, unstructured GBD into its autoinhibited conformation, suggesting that wiskostatin functions by stabilizing N-WASP in its autoinhibited state. The use of small molecules to bias conformational equilibria represents a potentially general strategy for chemical inhibition of autoinhibited proteins, even in cases where such sites have not been naturally evolved in a target.
PubMed: 15235593
DOI: 10.1038/nsmb796
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

236371

PDB entries from 2025-05-21

PDB statisticsPDBj update infoContact PDBjnumon